Trials / Completed
CompletedNCT03897192
Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis
Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (actual)
- Sponsor
- Changhua Christian Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
To report the long term prognosis in patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) and associated zonal outer retinopathy (ZOR).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab | Anti-vascular endothelial growth factor (VEGF) |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2019-01-31
- Completion
- 2019-03-20
- First posted
- 2019-04-01
- Last updated
- 2019-04-01
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03897192. Inclusion in this directory is not an endorsement.